市场调查报告书
商品编码
1597121
到 2031 年亚太地区血气和电解质分析仪市场预测 - 区域分析 - 按产品和最终用户Asia Pacific Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User |
2023年亚太地区血气及电解质分析仪市值为3.0333亿美元,预计2031年将达5.3184亿美元;预计2023年至2031年复合年增长率为7.3%。
新产品的推出和批准推动亚太地区血气和电解质分析仪市场
医疗保健产业的发展导致全球医疗保健提供者对血液气体和电解质分析仪的需求增加。这种需求的增加有助于全球范围内的新产品开发、产品发布和批准。此外,主要市场参与者都参与研发活动,以确保高效产品的创新和开发。以下是近期的一些产品发布和开发:
2023 年 7 月,西门子 Healthineers 推出了用于临床化学和免疫分析测试的新型 Atellica CI 分析仪。该分析仪在首次亮相之前就获得了美国食品和药物管理局 (FDA) 的批准。目前可以在多个国际地点访问它。 2022 年 7 月,在第 74 届美国临床化学协会年度科学会议和临床实验室博览会 (2022 AACC) 上,EDAN Instruments, Inc. 宣布推出首款基于即时护理 (POC) 萤光的 CO- OX 血气和化学分析系统,i20。该系统具有超过 45 个参数,从血气到电解质再到 CO 血氧饱和度。 2021 年 9 月,Sensa Core Medical Instrumentation APAC 推出了 ST-200 CC 血液气体分析仪 - 超智能,适用于诊所、医院和诊断中心。该公司最先进的血气模型是 ST-200 CC 超智慧 ABGEM 血气分析仪。它是一种全自动、微处理器控制的电解质系统,可透过离子选择性电极 (ISE)、阻抗 (Hct) 和电流分析 (pO2) 技术使用电流直接测量来执行动脉血气分析和电解质测量。 2021 年 4 月,西门子健康欧盟推出了 epoc 血液分析系统,这是一种无线便携式设备,可在一分钟内提供患者端结果。它透过一张室温稳定测试卡、完整血气和基本代谢组来测量血球比容和乳酸。它得到了对 COVID-19 应对工作的支持,因为血液检测对于管理感染者至关重要。因此,市场参与者之间产品开发、发布和策略合作的增加可能会在未来几年为血气和电解质分析仪市场创造充足的机会。
亚太地区血气及电解质分析仪市场概况
亚太地区血气和电解质分析仪市场分为中国、日本、澳洲、印度、韩国和亚太其他地区。由于印度、澳洲和韩国等国家对肾臟和呼吸系统疾病的认识不断提高,亚太地区的血气和电解质分析仪市场预计将大幅成长。由于日本和中国等国家医疗器材产业的不断发展,预计该市场还将成长。此外,预计这些国家呼吸部门的发展将推动预测期内的市场成长。
亚太地区血气及电解质分析仪市场收入及 2031 年预测(百万美元)
亚太地区血气和电解质分析仪市场细分
亚太地区血气和电解质分析仪市场按产品、最终用户和国家/地区进行分类。
根据产品,亚太地区血气和电解质分析仪市场分为血液气体分析仪、电解质分析仪、组合分析仪等。组合分析仪细分市场在 2023 年占据最大的市场份额。
按最终用户划分,亚太地区血气和电解质分析仪市场分为医院和诊所、临床和诊断实验室、家庭护理等。 2023 年,临床和诊断实验室领域占据最大的市场份额。
按国家/地区划分,亚太地区血气和电解质分析仪市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年,中国在亚太地区血气和电解质分析仪市场份额中占据主导地位。
Abbott Laboratories、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、Siemens Healthineers AG、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是一些领先的公司在亚太地区血气和电解质分析仪市场运作。
The Asia Pacific blood gas and electrolyte analyzer market was valued at US$ 303.33 million in 2023 and is projected to reach US$ 531.84 million by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031.
New Product Launches and Approvals Boost Asia Pacific Blood Gas and Electrolyte Analyzer Market
The development of the healthcare industry has led to a rise in the demand for blood gas and electrolyte analyzers among healthcare providers across the world. This increased demand contributes to new product developments, product launches, and approvals on a global level. In addition, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Following are a few of the recent product launches and developments:
In July 2023, Siemens Healthineers launched the new Atellica CI Analyser for clinical chemistry and immunoassay testing. The US Food and Drug Administration (FDA) permitted the analyzer before its debut. It is currently accessible in several international locations. In July 2022, at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), EDAN Instruments, Inc. announced the launch of the first-ever point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20. The system has over 45 parameters, ranging from blood gases to electrolytes to CO-oximetry. In September 2021, Sensa Core Medical Instrumentation APAC launched ST-200 CC Blood Gas Analyzers - Ultra Smart for use in clinics, hospitals, and diagnostic centers. The highly advanced blood gas model from the company is the ST-200 CC Ultra Smart ABGEM blood gas analyzer. It is a fully automated, microprocessor-controlled electrolyte system that performs arterial blood gas analysis and electrolyte measurements using current direct measurement with ION selective electrode (ISE), impedance (Hct), and amperometry (pO2) technologies. In April 2021, Siemens Healthiness EU launched the epoc Blood Analysis System, a wireless, portable device that provides patient-side results in less than a minute. It measures hematocrit and lactate on a single room temperature-stable test card, complete blood gas, and a basic metabolic panel. It is aided by its support of COVID-19 response efforts, as blood gas testing is essential for managing infected individuals. Thus, an increase in product developments, launches, and strategic collaborations among market players is likely to create ample opportunities for the blood gas and electrolyte analyzers market in the coming years.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Overview
The Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The blood gas and electrolyte analyzer market in Asia Pacific is expected to grow considerably owing to the rising awareness regarding kidney and respiratory diseases in countries such as India, Australia, and South Korea. The market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, the development in the respiratory sectors across these countries is estimated to fuel the market growth during the forecast period.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Blood Gas and Electrolyte Analyzer Market Segmentation
The Asia Pacific blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the Asia Pacific blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the Asia Pacific blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Asia Pacific blood gas and electrolyte analyzer market.